Global Cystic Fibrosis Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Cystic Fibrosis Drugs Market Overview

• 1.1 Product Overview and Scope of Cystic Fibrosis Drugs
• 1.2 Cystic Fibrosis Drugs Segment by Type
  • 1.2.1 Global Cystic Fibrosis Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Oral
  • 1.2.3 Injection
• 1.3 Cystic Fibrosis Drugs Segment by Application
  • 1.3.1 Cystic Fibrosis Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Other
• 1.3 Global Cystic Fibrosis Drugs Market by Region
  • 1.3.1 Global Cystic Fibrosis Drugs Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Cystic Fibrosis Drugs Market Size
  • 1.4.1 Global Cystic Fibrosis Drugs Revenue (2014-2025)
  • 1.4.2 Global Cystic Fibrosis Drugs Production (2014-2025)

2 Global Cystic Fibrosis Drugs Market Competition by Manufacturers

• 2.1 Global Cystic Fibrosis Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Cystic Fibrosis Drugs Production Sites, Area Served, Product Types
• 2.5 Cystic Fibrosis Drugs Market Competitive Situation and Trends
  • 2.5.1 Cystic Fibrosis Drugs Market Concentration Rate
  • 2.5.2 Cystic Fibrosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Cystic Fibrosis Drugs Production Market Share by Regions

• 3.1 Global Cystic Fibrosis Drugs Production Market Share by Regions
• 3.2 Global Cystic Fibrosis Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Cystic Fibrosis Drugs Production
  • 3.4.1 North America Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Cystic Fibrosis Drugs Production
  • 3.5.1 Europe Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Cystic Fibrosis Drugs Production (2014-2019)
  • 3.6.1 China Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Cystic Fibrosis Drugs Production (2014-2019)
  • 3.7.1 Japan Cystic Fibrosis Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Cystic Fibrosis Drugs Consumption by Regions

• 4.1 Global Cystic Fibrosis Drugs Consumption by Regions
• 4.2 North America Cystic Fibrosis Drugs Consumption (2014-2019)
• 4.3 Europe Cystic Fibrosis Drugs Consumption (2014-2019)
• 4.4 China Cystic Fibrosis Drugs Consumption (2014-2019)
• 4.5 Japan Cystic Fibrosis Drugs Consumption (2014-2019)

5 Global Cystic Fibrosis Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Cystic Fibrosis Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Cystic Fibrosis Drugs Price by Type (2014-2019)
• 5.4 Global Cystic Fibrosis Drugs Production Growth by Type (2014-2019)

6 Global Cystic Fibrosis Drugs Market Analysis by Applications

• 6.1 Global Cystic Fibrosis Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Cystic Fibrosis Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Cystic Fibrosis Drugs Business

• 7.1 Actavis
  • 7.1.1 Actavis Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.1.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.1.3 Actavis Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 F. Hoffmann-La Roche
  • 7.2.1 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.2.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Gilead Sciences
  • 7.3.1 Gilead Sciences Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.3.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.3.3 Gilead Sciences Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Novartis
  • 7.4.1 Novartis Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.4.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.4.3 Novartis Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Vertex Pharmaceuticals
  • 7.5.1 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.5.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Abbott
  • 7.6.1 Abbott Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.6.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.6.3 Abbott Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Anthera Pharmaceuticals
  • 7.7.1 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.7.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Arcturus Therapeutics
  • 7.8.1 Arcturus Therapeutics Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.8.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Boehringer Ingelheim
  • 7.9.1 Boehringer Ingelheim Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.9.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Chiesi Farmaceutici
  • 7.10.1 Chiesi Farmaceutici Cystic Fibrosis Drugs Production Sites and Area Served
  • 7.10.2 Cystic Fibrosis Drugs Product Introduction, Application and Specification
  • 7.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Corbus Pharmaceuticals
• 7.12 Genzyme
• 7.13 Insmed
• 7.14 Johnson & Johnson
• 7.15 Merck Sharp & Dohme
• 7.16 Neovii Biotech
• 7.17 Novo Nordisk
• 7.18 PharmaSwiss
• 7.19 Pharmaxis
• 7.20 Proteostasis Therapeutics
• 7.21 PTC Therapeutics
• 7.22 United Medical
• 7.23 Venus Remedies

8 Cystic Fibrosis Drugs Manufacturing Cost Analysis

• 8.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
• 8.4 Cystic Fibrosis Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Cystic Fibrosis Drugs Distributors List
• 9.3 Cystic Fibrosis Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Cystic Fibrosis Drugs Market Forecast

• 11.1 Global Cystic Fibrosis Drugs Production, Revenue Forecast
  • 11.1.1 Global Cystic Fibrosis Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Cystic Fibrosis Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Cystic Fibrosis Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Cystic Fibrosis Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Cystic Fibrosis Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Cystic Fibrosis Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Cystic Fibrosis Drugs Consumption Forecast (2019-2025)
• 11.4 Global Cystic Fibrosis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Cystic Fibrosis Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List